Accéder au contenu
Merck
Toutes les photos(1)

Principaux documents

1343550

USP

Iodixanol Related Compound D

United States Pharmacopeia (USP) Reference Standard

Synonyme(s) :

Iopentol, 5-[Acetyl(2-hydroxy-3-methylpropyl)amino]-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C20H28I3N3O9
Numéro CAS:
89797-00-2
Poids moléculaire :
835.16
Code UNSPSC :
41116107
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

iodixanol

Fabricant/nom de marque

USP

Application(s)

pharmaceutical (small molecule)

Format

neat

InChI

1S/C20H28I3N3O9/c1-9(29)26(5-12(32)8-35-2)18-16(22)13(19(33)24-3-10(30)6-27)15(21)14(17(18)23)20(34)25-4-11(31)7-28/h10-12,27-28,30-32H,3-8H2,1-2H3,(H,24,33)(H,25,34)

Clé InChI

IUNJANQVIJDFTQ-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Iodixanol Related Compound D USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monographs such as:
  • Iodixanol Injection
  • Iodixanol

Remarque sur l'analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

Y0001294

Iodixanol, European Pharmacopoeia (EP) Reference Standard

Y0001292

Iodixanol impurity C, European Pharmacopoeia (EP) Reference Standard

Y0001291

Iodixanol impurity E, European Pharmacopoeia (EP) Reference Standard

Y0001293

Iodixanol impurity H, European Pharmacopoeia (EP) Reference Standard

1343517

Iodixanol, United States Pharmacopeia (USP) Reference Standard

1343540

Iodixanol Related Compound C, United States Pharmacopeia (USP) Reference Standard

1343561

Iodixanol Related Compound E, United States Pharmacopeia (USP) Reference Standard

PHR3015

Iodixanol, pharmaceutical secondary standard, certified reference material

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

J E Roos et al.
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 176(4), 556-563 (2004-04-17)
To evaluate the impact of different iodine concentrations of intravenous contrast agent on hepatic and vascular enhancement during arterial and porto-venous phase imaging using a 4-channel multi-detector row CT (MDCT). One hundred consecutive patients referred for triphasic abdominal MDCT were
Steffen Ross et al.
AJR. American journal of roentgenology, 190(5), 1380-1389 (2008-04-24)
The objective of our study was to establish a standardized procedure for postmortem whole-body CT-based angiography with lipophilic and hydrophilic contrast media solutions and to compare the results of these two methods. Minimally invasive postmortem CT angiography was performed on
P Dewachter et al.
Journal de radiologie, 82(9 Pt 1), 973-977 (2001-10-10)
The etiology of severe reactions following injection of iodinated contrast agents is the subject of controversy. No consensus has been established regarding the management of patients at risk, risk factors and premedication because in most cases published no diagnostic exploration
K Katsanos et al.
Clinical hemorheology and microcirculation, 39(1-4), 87-91 (2008-05-27)
Iodinated contrast media (CM) are widely used in diagnostic imaging and therapeutic interventional procedures of everyday clinical practice and are associated with multiple hemodynamic and hemorheological effects. The purpose of our work was to investigate the red blood cell (RBC)
G Jung et al.
Journal of computer assisted tomography, 24(5), 783-787 (2000-10-25)
To evaluate the diagnostic value of MR imaging in abdominal lymphoma staging, in comparison with that of the established spiral CT, within the context of a prospective study. 50 patients with non-Hodgkin (n = 27) and Hodgkin lymphoma (n =
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique